Creston PLC
16 April 2008
Creston plc
Purchase of own shares
Creston plc announces that on 15 April 2008, the Creston plc Employee Benefit
Trust ("the EBT") purchased 1,349,549 ordinary shares of 10 pence each at a
price of 69.25 pence per share.
This purchase, from the vendors of CML Research Limited, enables those vendors
to satisfy their obligations under the Sale and Purchase Agreement dated 3
September 2004 with Creston plc. In accordance with that agreement they are to
pay Creston plc £0.9million. Both vendors have agreed new service agreements
plus three year incentive plans and are committed to the further development of
the Creston qualitative research offering.
The purchased shares will be held to satisfy obligations under the Creston plc
Long Term Incentive Plan. Following the above purchase, Creston plc holds
114,824 ordinary shares in treasury, 1,750,213 ordinary shares in the EBT and
has 55,646,414 ordinary shares in issue (excluding treasury shares).
For further information, please contact:
Creston plc 020 7930 9757
Don Elgie, Chief Executive
Barrie Brien, COO & CFO
www.creston.com
Hogarth Partnership Limited 020 7357 9477
Chris Matthews
Sarah Macleod
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.